Perkin Elmer – new member
Partner with PerkinElmer to enhance and streamline your biotherapeutics workflow from target discovery to manufacturing and quality control.
Read moreHEPHAISTOS Pharma – New member
HEPHAISTOS Pharma is a preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers.
Read morePolyplus-transfection® further expands transfection reagent portfolio for Cell and Gene therapy GMP production
Polyplus-transfection® further expands transfection reagent portfolio for Cell and Gene therapy GMP production
Read morePeptinov – new member
Peptinov is a privately held biotechnology company focused on the development of peptide-based immunotherapies targeting self-proteins, for the treatment of chronic inflammatory diseases and cancers.
Read moreInovotion launches the first rapid in vivo evaluation test of therapeutic combination efficacy using PD1 / PD-L1
With its expertise in early in vivo evaluation of efficacy in oncology, Inovotion has initiated an R&D program for developing a fast, reliable and perfectly predictive test for in vivo proof-of-concepts on synergistic treatments including checkpoint inhibitors, small molecule compounds, ADCs (Antibody Drug Conjugates), or even radiation therapy.
Read more